Semler Scientific Operating Margin 2013-2025 | SMLR
Current and historical operating margin for Semler Scientific (SMLR) over the last 10 years. The current operating profit margin for Semler Scientific as of June 30, 2025 is 219.61%.
| Semler Scientific Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-06-30 | $0.04B | $-0.02B | -55.81% |
| 2025-03-31 | $0.05B | $-0.02B | -34.69% |
| 2024-12-31 | $0.06B | $0.02B | 37.50% |
| 2024-09-30 | $0.06B | $0.02B | 33.90% |
| 2024-06-30 | $0.06B | $0.02B | 34.43% |
| 2024-03-31 | $0.07B | $0.02B | 34.85% |
| 2023-12-31 | $0.07B | $0.02B | 32.35% |
| 2023-09-30 | $0.07B | $0.02B | 34.33% |
| 2023-06-30 | $0.07B | $0.02B | 32.31% |
| 2023-03-31 | $0.06B | $0.02B | 31.15% |
| 2022-12-31 | $0.06B | $0.02B | 29.82% |
| 2022-09-30 | $0.06B | $0.02B | 27.27% |
| 2022-06-30 | $0.06B | $0.02B | 29.09% |
| 2022-03-31 | $0.05B | $0.02B | 31.48% |
| 2021-12-31 | $0.05B | $0.02B | 35.85% |
| 2021-09-30 | $0.05B | $0.02B | 43.40% |
| 2021-06-30 | $0.05B | $0.02B | 48.00% |
| 2021-03-31 | $0.04B | $0.02B | 45.24% |
| 2020-12-31 | $0.04B | $0.02B | 42.11% |
| 2020-09-30 | $0.04B | $0.01B | 37.14% |
| 2020-06-30 | $0.03B | $0.01B | 30.30% |
| 2020-03-31 | $0.04B | $0.01B | 34.29% |
| 2019-12-31 | $0.03B | $0.01B | 33.33% |
| 2019-09-30 | $0.03B | $0.01B | 30.00% |
| 2019-06-30 | $0.03B | $0.01B | 29.63% |
| 2019-03-31 | $0.02B | $0.01B | 29.17% |
| 2018-12-31 | $0.02B | $0.01B | 28.57% |
| 2018-09-30 | $0.02B | $0.01B | 26.32% |
| 2018-06-30 | $0.02B | $0.00B | 17.65% |
| 2018-03-31 | $0.02B | 0 | 0.00% |
| 2017-12-31 | $0.01B | $0.00B | -15.38% |
| 2017-09-30 | $0.01B | $0.00B | -18.18% |
| 2017-06-30 | $0.01B | $0.00B | -22.22% |
| 2017-03-31 | $0.01B | $0.00B | -25.00% |
| 2016-12-31 | $0.01B | $0.00B | -25.00% |
| 2016-09-30 | $0.01B | $-0.01B | -66.67% |
| 2016-06-30 | $0.01B | $-0.01B | -88.89% |
| 2016-03-31 | $0.01B | $-0.01B | -100.00% |
| 2015-12-31 | $0.01B | $-0.01B | -114.29% |
| 2015-09-30 | $0.01B | $-0.01B | -100.00% |
| 2015-06-30 | $0.00B | $0.00B | -100.00% |
| 2015-03-31 | $0.00B | $0.00B | -100.00% |
| 2014-12-31 | $0.00B | $0.00B | -100.00% |
| 2014-09-30 | $0.00B | $0.00B | -100.00% |
| 2014-06-30 | $0.00B | $0.00B | -75.00% |
| 2014-03-31 | $0.00B | $0.00B | -100.00% |
| 2013-12-31 | $0.00B | $0.00B | -150.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.456B | $0.056B |
| Semler Scientific, Inc. is a medical risk-assessment company. The Company engages in developing, manufacturing, and marketing patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Its products include FloChec (R) which is used in the office setting to allow healthcare providers to measure arterial blood flow in the extremities and is a useful tool for internists and primary care physicians. Semler Scientific, Inc. is headquartered in Portland, Oregon. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | US | $184.456B | 22.32 |
| Intuitive Surgical (ISRG) | United States | $170.011B | 70.47 |
| IDEXX Laboratories (IDXX) | United States | $51.341B | 53.43 |
| Edwards Lifesciences (EW) | United States | $47.714B | 31.62 |
| Alcon (ALC) | Switzerland | $40.175B | 26.97 |
| IQVIA Holdings (IQV) | United States | $31.919B | 18.04 |
| DexCom (DXCM) | United States | $29.851B | 44.78 |
| Mettler-Toledo (MTD) | United States | $26.465B | 31.41 |
| STERIS (STE) | IE | $24.483B | 26.06 |
| Waters (WAT) | US | $17.627B | 24.21 |
| SONOVA HOLDING (SONVY) | CH | $16.949B | 0.00 |
| Hologic (HOLX) | United States | $14.820B | 16.06 |
| Penumbra (PEN) | US | $10.374B | 75.78 |
| Globus Medical (GMED) | United States | $8.357B | 19.28 |
| Sysmex ADR (SSMXY) | JP | $8.133B | 25.84 |
| Masimo (MASI) | United States | $7.782B | 26.19 |
| Teleflex (TFX) | US | $5.623B | 9.08 |
| Glaukos (GKOS) | United States | $5.379B | 0.00 |
| TransMedics (TMDX) | US | $3.927B | 59.68 |
| Integer Holdings (ITGR) | United States | $3.800B | 18.96 |
| LivaNova (LIVN) | United Kingdom | $3.090B | 17.68 |
| Veracyte (VCYT) | US | $2.287B | 31.60 |
| PROCEPT BioRobotics (PRCT) | US | $2.254B | 0.00 |
| Artivion (AORT) | United States | $2.078B | 104.83 |
| Nihon Kohden (NHNKY) | JP | $1.950B | 23.28 |
| Elekta AB (EKTAY) | Sweden | $1.864B | 17.43 |
| Integra LifeSciences Holdings (IART) | United States | $1.150B | 6.59 |
| Pulse Biosciences (PLSE) | US | $1.138B | 0.00 |
| OPKO Health (OPK) | US | $1.103B | 0.00 |
| IRadimed (IRMD) | United States | $0.925B | 44.87 |
| Tandem Diabetes Care (TNDM) | US | $0.827B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.797B | 0.00 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | US | $0.708B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | US | $0.573B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.555B | 0.00 |
| Treace Medical Concepts (TMCI) | US | $0.470B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.398B | 0.00 |
| Pacific Biosciences Of California (PACB) | US | $0.396B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.67 |
| Mesa Laboratories (MLAB) | United States | $0.381B | 9.70 |
| RxSight (RXST) | US | $0.348B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.302B | 0.00 |
| NeuroPace (NPCE) | US | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | US | $0.290B | 20.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.282B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.280B | 0.00 |
| 908 Devices (MASS) | United States | $0.228B | 0.00 |
| Neuronetics (STIM) | US | $0.224B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.223B | 0.00 |
| Sight Sciences (SGHT) | US | $0.222B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.198B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.150B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.128B | 0.00 |
| Rapid Micro Biosystems (RPID) | US | $0.117B | 0.00 |
| InspireMD (NSPR) | US | $0.103B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.091B | 0.00 | |
| QT Imaging Holdings (QTIH) | US | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | US | $0.054B | 0.00 |
| WORK Medical Technology Group (WOK) | CN | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | US | $0.039B | 0.00 |
| Precision Optics (POCI) | US | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | US | $0.019B | 0.00 |
| EnVVeno Medical (NVNO) | US | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Tenon Medical (TNON) | US | $0.012B | 0.00 |
| PAVmed (PAVM) | US | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | US | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | US | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | CA | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | US | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | US | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | US | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.48 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |